Brief: Aileron Therapeutics Says Appointed Timothy Cunningham As Interim CFO
16/05/2024 22:24
May 16 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS INC - ON MAY 15 APPOINTED TIMOTHY M.
CUNNINGHAM AS INTERIM CHIEF FINANCIAL OFFICER, EFFECTIVE AS OF
MAY 16
Source text for Eikon: ID:n0001193125-24-140688
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering